Eli Lilly to acquire CrossBridge Bio for up to $300 million
Go back to Eli Lilly to acquire CrossBridge Bio for up to $300 million| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1104.46 +2.38 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1117.00 | 52 Week Low | $67.88 | |||
| Day High | $1122.02 | P/E | 255.66 | |||
| Day Low | $1100.55 | EPS | $4.32 | |||
| Volume | 539,053 | |||||

